NASDAQ$ACHC
Acadia Healthcare Company Inc. · Q1 2026 earnings
Q1 2026 earnings · · Investor relations
Briefing
ACHC reported Q1 2026 results and net income of N/A.
For Q1 2026, ACHC reported results. MD&A discusses segment trends, costs, and balance-sheet items; The quarter reflected bottom-line pressure versus the prior year.
- Key P&L metrics disclosed for Q1 2026.
- Net income/loss detailed in the quarterly filing.
- Operating expenses and margin mix are discussed in MD&A.
- Liquidity, capital allocation, and macro exposure are disclosed.
Headline financials
Revenue & EPS history
Acadia Healthcare · Revenue · Quarterly
$829M
Forward guidance
Management outlook in the 10-Q covers operating priorities, capital allocation, and sector risks; numeric multi-quarter EPS bridges are limited.
Tailwinds
- MD&A highlights strategic priorities and liquidity.
- Segment or product trends support the core business narrative.
Headwinds
- Macro, rates, or input costs may pressure near-term margins.
- One-time items can affect year-over-year comparability.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2026
+1.5%
Avg return
Earnings day
+1.4%
Avg return
5 days after
+2.5%
Avg return
30 days after
60%
38 / 63 earnings
Positive
+23.1%
Q3 2020
Best reaction
-26.9%
Q3 2017
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +2.5% | +0.3% | -16.0% | |
| Q4 2025 | +21.4% | +36.5% | +33.4% | |
| Q3 2025 | -5.5% | -10.2% | -25.2% | |
| Q1 2025 | +4.2% | +1.2% | -14.4% | |
| Q4 2024 | -25.5% | -26.3% | -25.2% | |
| Q3 2024 | -17.3% | -18.0% | -21.3% | |
| Q2 2024 | +10.0% | +5.4% | +21.6% | |
| Q1 2024 | -9.8% | -8.3% | -6.8% | |
| Q4 2023 | -2.4% | -1.8% | -7.3% | |
| Q3 2023 | -1.7% | +1.1% | +0.5% | |
| Q2 2023 | +7.8% | +6.5% | +2.9% | |
| Q1 2023 | -1.3% | -4.4% | -6.0% | |
| Q4 2022 | -9.6% | -7.3% | -12.1% | |
| Q3 2022 | -3.4% | -5.5% | +7.2% | |
| Q2 2022 | +3.6% | +3.9% | +4.8% | |
| Q1 2022 | +8.0% | +5.4% | +6.4% | |
| Q4 2021 | +6.5% | +9.3% | +15.3% | |
| Q3 2021 | +10.5% | +11.8% | +3.0% | |
| Q2 2021 | +3.1% | +1.3% | +8.0% | |
| Q1 2021 | -1.1% | +1.1% | +4.4% | |
| Q4 2020 | +1.5% | +2.5% | +6.0% | |
| Q3 2020 | +23.1% | +28.7% | +49.1% | |
| Q2 2020 | +2.3% | +2.7% | -0.1% | |
| Q1 2020 | +16.7% | +18.2% | +26.7% | |
| Q4 2019 | -5.9% | +6.0% | +100.5% | |
| Q3 2019 | -3.5% | -2.0% | +2.5% | |
| Q2 2019 | -3.3% | -12.0% | -19.6% | |
| Q1 2019 | +0.0% | +3.2% | +1.4% | |
| Q4 2018 | +15.9% | +11.7% | +11.7% | |
| Q3 2018 | -12.8% | -5.0% | -26.0% | |
| Q2 2018 | -10.6% | -7.4% | -8.0% | |
| Q1 2018 | +9.0% | +11.7% | +13.0% | |
| Q4 2017 | +8.5% | +6.8% | +8.4% | |
| Q3 2017 | -26.9% | -25.6% | -30.7% | |
| Q2 2017 | +7.6% | +5.7% | -7.5% | |
| Q1 2017 | -3.1% | +0.0% | -2.4% | |
| Q4 2016 | +5.4% | +4.9% | -1.7% | |
| Q3 2016 | +3.1% | +3.8% | +5.9% | |
| Q2 2016 | -1.3% | -0.8% | -4.8% | |
| Q1 2016 | -0.8% | — | — | |
| Q4 2015 | +5.7% | — | — | |
| Q3 2015 | +9.4% | — | — | |
| Q2 2015 | +3.4% | — | — | |
| Q1 2015 | -2.9% | — | — | |
| Q4 2014 | -0.4% | — | — | |
| Q3 2014 | +11.2% | — | — | |
| Q2 2014 | -2.1% | — | — | |
| Q1 2014 | +0.4% | — | — | |
| Q4 2013 | -2.8% | — | — | |
| Q3 2013 | +9.0% | — | — | |
| Q2 2013 | +8.2% | — | — | |
| Q1 2013 | +2.9% | — | — | |
| Q4 2009 | +2.3% | — | — | |
| Q4 2012 | +0.1% | — | — | |
| Q3 2012 | +2.3% | — | — | |
| Q2 2012 | +7.5% | — | — | |
| Q2 2011 | +4.4% | — | — | |
| Q1 2012 | +6.5% | — | — | |
| Q1 2011 | -1.0% | — | — | |
| Q4 2011 | +3.3% | — | — | |
| Q4 2010 | +0.1% | — | — | |
| Q3 2011 | +0.1% | — | — | |
| Q3 2010 | +0.1% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro